First Wave BioPharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of First Wave BioPharma generated cash of -$12,377,852, which is more than the previous year. Cash used in financing activities reached the amount of $15,226,721 last year. Net change in cash is therefore $2,348,860.
Cash Flow
| 2014 | -1.01K | -751 | 1.85K |
|---|---|---|---|
| 2015 | -4.51M | -24.38K | 5.02M |
| 2016 | -4.53M | -12.35K | 5.74M |
| 2017 | -7.18M | -32.16K | 6.01M |
| 2018 | -10.86M | -305.47K | 11.71M |
| 2019 | -14.03M | -24.09K | 13.14M |
| 2020 | -11.22M | 87.35K | 17.04M |
| 2021 | -32.28M | -10.31M | 44.76M |
| 2022 | -22.34M | 0 | 15.73M |
| 2023 | -12.37M | -500K | 15.22M |
FWBI Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.36M | 8.24M | 6.06M | 175.79K | 1.11M | 573.47K | 1.77M | 581.66K | 94.83K | 48 |
Operating activities | ||||||||||
Net income | -15.79M | -14.62M | -58.53M | -32.67M | -15.17M | -13.53M | -11.09M | -14.59M | -5.93M | -2.95K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 29.27K | 29.27K | 542.25K | 565.34K | 1.02M | 798.44K | 753.99K | 734.5K | 733.59K | 434 |
Stock-based compensation expense | 1.04M | 769.12K | 1.37M | 549.42K | 1.18M | 0 | 609.36K | 603 | 0 | 0 |
| Deferred income tax benefit | 1.04M | 769.12K | 1.37M | 549.42K | 1.18M | 0 | 609.36K | 603 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 93.01K | -93.01K | 551.48K | 2.08M | -749.85K | -2.18M | 3.43K | 132.03K | -638.09K | 356 |
Inventories | 0 | 93.01K | -551.48K | -2.08M | 749.85K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -165.76K | -1.98M | 1.41M | -750.02K | -420.78K | 741.62K | -233.77K | 805.76K | 0 | 0 |
Cash generated by operating activities | -12.37M | -22.34M | -32.28M | -11.22M | -14.03M | -10.86M | -7.18M | -4.53M | -4.51M | -1.01K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -500K | 0 | -10.31M | -4.16K | -24.09K | -55.47K | -32.16K | -12.35K | -24.38K | -191 |
Acquisitions Net | 0 | 0 | 0 | 91.51K | 0 | 0 | 0 | 0 | 0 | -560 |
Cash generated by investing activities | -500K | 0 | -10.31M | 87.35K | -24.09K | -305.47K | -32.16K | -12.35K | -24.38K | -751 |
Financing activities | ||||||||||
Common Stock Issued | 0 | 23.29M | 26.16M | 0 | 9.47M | 0 | 5.00M | 5.28M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 1.74M | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 88.83K | 0 | 0 | 0 | 0 | -439.59K | 0 | 0 |
Cash used in financing activities | 15.22M | 15.73M | 44.76M | 17.04M | 13.14M | 11.71M | 6.01M | 5.74M | 5.02M | 1.85K |
Net Change In Cash | 2.34M | -6.86M | 2.18M | 5.88M | -938.54K | 540.87K | -1.20M | 1.19M | 486.83K | 85 |
Cash at end of period | 3.71M | 1.38M | 8.24M | 6.06M | 175.79K | 1.11M | 573.47K | 1.77M | 581.66K | 133 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |